Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy
NCT ID: NCT01772160
Last Updated: 2020-05-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
395 participants
OBSERVATIONAL
2013-02-26
2016-10-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Herpes Zoster Hospitalizations in Italy
NCT05952271
Measuring Herpes Zoster and PHN Associated Burden of Illness and Health Care Utilization Costs in Thailand
NCT00526864
Burden of Hepatitis D Virus (HDV) Infection in Italy
NCT05723068
This Study Aims to Determine the Incidence, of Hepatitis B Diagnosis Among Diabetes Mellitus Patients of 0-80 Years of Age
NCT02324218
Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis
NCT01160081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The data will be captured at protocol specified time-points based on the time of enrolment of each subject.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Herpes Zoster Group
Male or female subjects aged 50 years or above, presenting with a herpes zoster (HZ) episode.
Data collection
HZ/PHN booklet, HZ/PHN file and logbook. HZ/PHN booklet will be completed by the patient and the HZ/PHN file and logbook will be completed by the participating general practitioner.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
HZ/PHN booklet, HZ/PHN file and logbook. HZ/PHN booklet will be completed by the patient and the HZ/PHN file and logbook will be completed by the participating general practitioner.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HZ diagnosis for this HZ episode:
* Is his/her first outpatient diagnosis (i.e. initial consultation), OR
* Took place at another site/centre (e.g. emergency room or Dermatologist/Specialist practice) provided the HZ diagnosis is not more than 7 days before the initial visit for the present study (i.e. secondary consultation).
* Written informed consent obtained from the patient.
* Ability to comply with study procedures.
Exclusion Criteria
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GlaxoSmithKline
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
GSK Clinical Trials
Role: STUDY_DIRECTOR
GlaxoSmithKline
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
GSK Investigational Site
Cavallino (LE), Apulia, Italy
GSK Investigational Site
Copertino (LE), Apulia, Italy
GSK Investigational Site
Cutrofiano (LE), Apulia, Italy
GSK Investigational Site
Galatina (LE), Apulia, Italy
GSK Investigational Site
Montesano S. (LE), Apulia, Italy
GSK Investigational Site
Parabita (LE), Apulia, Italy
GSK Investigational Site
Specchia (LE), Apulia, Italy
GSK Investigational Site
Napoli, Campania, Italy
GSK Investigational Site
Napoli, Campania, Italy
GSK Investigational Site
Rome, Lazio, Italy
GSK Investigational Site
Rome, Lazio, Italy
GSK Investigational Site
Rome, Lazio, Italy
GSK Investigational Site
Rome, Lazio, Italy
GSK Investigational Site
Rome, Lazio, Italy
GSK Investigational Site
Rome, Lazio, Italy
GSK Investigational Site
Angera (VA), Lombardy, Italy
GSK Investigational Site
Arcisate (VA), Lombardy, Italy
GSK Investigational Site
Comerio (VA), Lombardy, Italy
GSK Investigational Site
Fagnano Olona (VA), Lombardy, Italy
GSK Investigational Site
Ghirla Valganna (VA), Lombardy, Italy
GSK Investigational Site
Induno Olona (VA), Lombardy, Italy
GSK Investigational Site
Sesto Calende (VA), Lombardy, Italy
GSK Investigational Site
Solbiate Olona (VA), Lombardy, Italy
GSK Investigational Site
Varese, Lombardy, Italy
GSK Investigational Site
Alessandria, Piedmont, Italy
GSK Investigational Site
Frugarolo (AL), Piedmont, Italy
GSK Investigational Site
Oviglio (AL), Piedmont, Italy
GSK Investigational Site
Sale (AL), Piedmont, Italy
GSK Investigational Site
Villalvernia (AL), Piedmont, Italy
GSK Investigational Site
Arcidosso (GR), Tuscany, Italy
GSK Investigational Site
Arezzo, Tuscany, Italy
GSK Investigational Site
Civitella Paganico (GR), Tuscany, Italy
GSK Investigational Site
Follonica (GR), Tuscany, Italy
GSK Investigational Site
Grosseto, Tuscany, Italy
GSK Investigational Site
Lucignano (AR), Tuscany, Italy
GSK Investigational Site
Orbetello (GR), Tuscany, Italy
GSK Investigational Site
Sassofortino (GR), Tuscany, Italy
GSK Investigational Site
Perugia, Umbria, Italy
GSK Investigational Site
Perugia, Umbria, Italy
GSK Investigational Site
Perugia, Umbria, Italy
GSK Investigational Site
Ripa (PG), Umbria, Italy
GSK Investigational Site
Alessano (LE), , Italy
GSK Investigational Site
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Salvetti A, Ferrari V, Garofalo R, Gazzaniga P, Guerroni A, Metrucci A, Sessa A, Severi ML, Nati G, Ruggeri M, Rossi A, Cappellari L, Gopala K, Tosatto R, Simone B. Incidence of herpes zoster and postherpetic neuralgia in Italian adults aged >/=50 years: A prospective study. Prev Med Rep. 2019 Apr 24;14:100882. doi: 10.1016/j.pmedr.2019.100882. eCollection 2019 Jun.
Matthews S, De Maria A, Passamonti M, Ristori G, Loiacono I, Puggina A, Curran D. The Economic Burden and Impact on Quality of Life of Herpes Zoster and Postherpetic Neuralgia in Individuals Aged 50 Years or Older in Italy. Open Forum Infect Dis. 2019 Jan 12;6(2):ofz007. doi: 10.1093/ofid/ofz007. eCollection 2019 Feb.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
116208
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.